Compare Cigna Corp (CI) vs Ciena (CIEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Ciena — how do they compare? Cigna Corp trades at $289.99 (market cap $76.34B), while Ciena trades at $346.15 (market cap $47.41B). The key difference: Cigna Corp is the larger of the two by market cap, and Cigna Corp pays a 2.16% dividend while Ciena pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cigna Corp for 64 Days and Ciena for 3 Days on average.
| CI | CIEN | |
|---|---|---|
Market Cap | $76.34B | $47.41B |
Volume | 1,107,394 | 2,791,062 |
Sector | Health | Technology |
52-Week High | $311.00 | $627.00 |
52-Week Low | $244.41 | $136.38 |
Typical Hold Time | 64 Days | 3 Days |
Enterprise Value | $101.05B | $48.07B |
Dividend Yield | 2.16% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna Group (CI) trades at $289.53, up 3.12% today, reflecting strong momentum amid a bullish technical signal. The stock exhibits solid fundamentals with a P/E of 12 and consistent earnings beats in recent quarters, including Q2 2026 EPS of $7.78 versus $7.60 expected. Revenue growth is robust, climbing to $273.85B in 2025, while analyst sentiment is overwhelmingly positive with 28 buy ratings and a $331 consensus price target. Recent corporate news includes an upcoming Investor Day on September 30, 2026, highlighting strategic initiatives.
The outlook for CI remains favorable, supported by earnings growth, shareholder returns via dividends, and institutional accumulation. Key risks include rising medical costs and debt levels, but the company's competitive positioning and operational cash flow generation provide a buffer. The stock presents a value opportunity with upside to analyst targets, though investors should monitor expense trends and regulatory developments in the healthcare sector.
Ciena Corporation (CIEN) trades at $334.33, down 4.35% in the last session, amid a technical bearish signal despite strong fundamental performance. The company reported Q2 2026 EPS of $2.11, beating expectations by 22%, with revenue growth driven by AI networking demand. Analyst consensus remains strongly bullish with a $476.60 price target, representing 43% upside potential from current levels.
Ciena's outlook is supported by robust AI-driven optical networking demand, a growing $8.5B+ backlog, and 30%+ revenue growth guidance for fiscal 2027. Key risks include supply chain constraints limiting growth conversion and premium valuation multiples requiring sustained execution. The stock presents a compelling growth opportunity if supply challenges can be managed effectively.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Ciena
Ciena provides networking systems, components, automation software, and services for high-speed connectivity. Its products are used to transmit and manage data across telecom, cloud, and data center networks.
Read more on CIEN →
